Skip to content
DraconiticResearch
Search Sources API
181,686 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BYFrontiers in Aging Neuroscience

Extracellular vesicles and Alzheimer’s disease: hotspots, trends, and future directions—a tri-database bibliometric analysis

  1. 1Department of Neurology, The First Affiliated Hospital of Dalian University, Dalian, China
  2. 2Department of Neurology, Anshan Central Hospital, Anshan, Liaoning, China

Abstract

BackgroundAlzheimer’s disease is a neurodegenerative disorder marked by progressive cognitive decline. The pathogenesis of AD is complex, and effective methods for early diagnosis and treatment are currently lacking. Extracellular vesicles, which are key mediators of intercellular communication, significantly influence the onset and progression of AD. Consequently, a systematic review of this field is essential.MethodsThis study utilized the WoSCC and Scopus databases to gather English “Articles” and “Reviews.” Following duplicate removal via Python, bibliometric methods systematically analyzed research hotspots and frontiers concerning extracellular vesicles in Alzheimer’s disease. The analysis encompassed publication trends, countries, institutions, authors, journals, keywords, and references. Concurrently, the PubMed database was searched to verify the robustness and consistency of the analysis results.ResultsThis study conducted a bibliometric analysis of 2,626 articles, with 1,614 articles from PubMed used for consistency verification. The findings indicate a continuous rise in research interest in this field. Key areas of focus include emerging pathological mechanisms, peripheral blood biomarkers, targeted drug delivery, miRNA, and clinical trials. Cross-database verification confirmed a strong consistency in publication trends, countries, institutions, and authors, with a significant overlap of keywords and prominent research hot spots.ConclusionThis study demonstrates a shift in the research focus on Extracellular vesicles within Alzheimer’s disease from single-pathology investigations to exploring multiple mechanisms. Their significance in precise diagnosis and targeted therapy is increasingly evident. However, clinical trials remain limited. Future efforts should prioritize enhancing clinical validation and standardizing isolation techniques.

Related

  1. Single molecule detection of Tau seeds in extracellular vesicles from Alzheimer's disease brains
    Dalya Gulseren, Anaïs Bécot, Bank Neuroceb Brain +2
    HALPreprintCC BY 4.0Full textGeneral biochemistryCell biologyHALbioRxiv
  2. Engineered mesenchymal stem cell-derived extracellular vesicles overexpressing miR-146a alleviate neuroinflammation in Alzheimer's disease.
    Jia Zhang, Siqi He, Qiguo Xiao +10
    PubMed CentralPeer-reviewedCC BYFull text9 citedMolecular biology & gene regulationOpenAlex
  3. Chromosome 14 MicroRNA Cluster Members in Brain-Derived Extracellular Vesicles Can Be Genotype-Associated Biomarker Candidates for Alzheimer’s Disease and Frontotemporal Dementia
    Joseph Morgan, Toby Aarons, Gemma Lace +1
    BiomoleculesPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMC
  4. Editorial: Investigating the role of extracellular vesicles in cardiovascular disease mechanisms
    Jona Benjamin Krohn, Elena Aikawa
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
  5. Editorial: Unlocking the potential of extracellular vesicles in tumor immunity and drug resistance
    Yu Fu, Tianzhao Du, Huizhe Xu +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
BibTeX
@article{wang2026extracellular,
  title = {{Extracellular vesicles and Alzheimer’s disease: hotspots, trends, and future directions—a tri-database bibliometric analysis}},
  author = {Xi Wang and Xi Wang and Bing-Wei Zhang},
  journal = {Frontiers in Aging Neuroscience},
  year = {2026},
  month = oct,
  doi = {10.3389/fnagi.2026.1951959},
  url = {https://doi.org/10.3389/fnagi.2026.1951959},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Extracellular vesicles and Alzheimer’s disease: hotspots, trends, and future directions—a tri-database bibliometric analysis
AU  - Xi Wang
AU  - Xi Wang
AU  - Bing-Wei Zhang
PY  - 2026
DA  - 2026/10/26
JO  - Frontiers in Aging Neuroscience
DO  - 10.3389/fnagi.2026.1951959
UR  - https://doi.org/10.3389/fnagi.2026.1951959
AB  - BackgroundAlzheimer’s disease is a neurodegenerative disorder marked by progressive cognitive decline. The pathogenesis of AD is complex, and effective methods for early diagnosis and treatment are currently lacking. Extracellular vesicles, which are key mediators of intercellular communication, significantly influence the onset and progression of AD. Consequently, a systematic review of this field is essential.MethodsThis study utilized the WoSCC and Scopus databases to gather English “Articles” and “Reviews.” Following duplicate removal via Python, bibliometric methods systematically analyzed research hotspots and frontiers concerning extracellular vesicles in Alzheimer’s disease. The analysis encompassed publication trends, countries, institutions, authors, journals, keywords, and references. Concurrently, the PubMed database was searched to verify the robustness and consistency of the analysis results.ResultsThis study conducted a bibliometric analysis of 2,626 articles, with 1,614 articles from PubMed used for consistency verification. The findings indicate a continuous rise in research interest in this field. Key areas of focus include emerging pathological mechanisms, peripheral blood biomarkers, targeted drug delivery, miRNA, and clinical trials. Cross-database verification confirmed a strong consistency in publication trends, countries, institutions, and authors, with a significant overlap of keywords and prominent research hot spots.ConclusionThis study demonstrates a shift in the research focus on Extracellular vesicles within Alzheimer’s disease from single-pathology investigations to exploring multiple mechanisms. Their significance in precise diagnosis and targeted therapy is increasingly evident. However, clinical trials remain limited. Future efforts should prioritize enhancing clinical validation and standardizing isolation techniques.
SN  - 1663-4365
ER  -